ZA968785B - Snatch block pins. - Google Patents

Snatch block pins.

Info

Publication number
ZA968785B
ZA968785B ZA9608785A ZA968785A ZA968785B ZA 968785 B ZA968785 B ZA 968785B ZA 9608785 A ZA9608785 A ZA 9608785A ZA 968785 A ZA968785 A ZA 968785A ZA 968785 B ZA968785 B ZA 968785B
Authority
ZA
South Africa
Prior art keywords
snatch block
block pins
wounds
healing
promoting
Prior art date
Application number
ZA9608785A
Other languages
English (en)
Inventor
Pharmaceutical Composition
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manchester filed Critical Univ Manchester
Publication of ZA968785B publication Critical patent/ZA968785B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Adornments (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9608785A 1995-10-21 1996-10-18 Snatch block pins. ZA968785B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9521608A GB2306481A (en) 1995-10-21 1995-10-21 Pharmaceutical comprising a stimulator of activin and/or inhibin

Publications (1)

Publication Number Publication Date
ZA968785B true ZA968785B (en) 1998-04-20

Family

ID=10782702

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9608785A ZA968785B (en) 1995-10-21 1996-10-18 Snatch block pins.

Country Status (13)

Country Link
US (1) US7713933B2 (xx)
EP (1) EP0855916B1 (xx)
JP (1) JP4102437B2 (xx)
AT (1) ATE275966T1 (xx)
AU (1) AU715255B2 (xx)
CA (1) CA2235412C (xx)
DE (1) DE69633396T2 (xx)
DK (1) DK0855916T3 (xx)
ES (1) ES2227610T3 (xx)
GB (1) GB2306481A (xx)
PT (1) PT855916E (xx)
WO (1) WO1997015321A1 (xx)
ZA (1) ZA968785B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004937A (en) * 1998-03-09 1999-12-21 Genetics Institute, Inc. Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11]
EP1237565B1 (en) * 1999-12-15 2006-03-08 Research Development Foundation Betaglycan as an inhibin receptor and uses thereof
JP4487376B2 (ja) 2000-03-31 2010-06-23 味の素株式会社 腎疾患治療剤
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
TW202021980A (zh) 2007-02-02 2020-06-16 美商艾瑟勒朗法瑪公司 衍生自ActRIIB的變體與其用途
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
CA2729100C (en) 2008-06-26 2018-01-02 Acceleron Pharma Inc. Methods for dosing an activin-actriia antagonist and monitoring of treated patients
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
AU2015269333B2 (en) 2014-06-04 2020-05-07 Acceleron Pharma, Inc. Methods and compositions for treatment of disorders with follistatin polypeptides
US10010498B2 (en) 2014-06-04 2018-07-03 Acceleron Pharma Inc. Methods for treatment of amyotrophic lateral sclerosis with follistatin fusion proteins
WO2016154601A1 (en) 2015-03-26 2016-09-29 Acceleron Pharma Inc. Follistatin-related fusion proteins and uses thereof
WO2017088027A1 (en) * 2015-11-26 2017-06-01 Prince Henry's Institute Of Medical Research Trading As The Hudson Institute Of Medical Research Inhibin analogs
CN115404199B (zh) * 2022-11-01 2023-03-21 广州优特佳生物科技发展有限公司 活化素b在促进透明质酸合成中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011862A1 (en) * 1988-05-31 1989-12-14 Biotechnology Australia Pty. Ltd. Actions of hormones
US5071834A (en) * 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
US4997815A (en) * 1988-11-01 1991-03-05 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
JPH0651638B2 (ja) * 1989-02-13 1994-07-06 新技術事業団 角膜上皮創傷治療用点眼剤
US5102868A (en) * 1990-01-08 1992-04-07 Genentech, Inc. Method for inhibiting follicular maturation
EP0515494A1 (en) * 1990-02-15 1992-12-02 Chiron Corporation Use of inhibitor of cytokine activity
WO1992004913A1 (en) * 1990-09-13 1992-04-02 Children's Hospital Medical Center Of Northern California Method for increasing red blood cell production by treatment with activin or activin-related peptides
US5216004A (en) * 1990-09-13 1993-06-01 Children's Hospital Medical Center Of North California Method for preventing malaria
US5208219A (en) * 1991-02-14 1993-05-04 Celtrix Pharmaceuticals Inc. Method for inducing bone growth
DK0575555T3 (da) 1991-03-11 2001-11-05 Curis Inc Proteininduceret morfogenese
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
US5885794A (en) 1991-05-10 1999-03-23 The Salk Institute For Biological Studies Recombinant production of vertebrate activin receptor polypeptides and identification of receptor DNAs in the activin/TGF-β superfamily
IL99867A0 (en) 1991-10-27 1992-08-18 Yissum Res Dev Co Pharmaceutical compositions containing activin a
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
US5428011A (en) * 1992-06-16 1995-06-27 Procyon Biopharma, Inc. Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma
US5753612A (en) 1992-10-27 1998-05-19 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
US5888720A (en) 1992-10-27 1999-03-30 Yissum Research And Development Company Of The Hebrew University Of Jerusalem In vitro micro-organs
JPH07149659A (ja) * 1993-09-28 1995-06-13 Ajinomoto Co Inc 骨損傷治療剤
JP4083794B2 (ja) * 1994-03-29 2008-04-30 レノボ・リミテッド 創傷の治癒
AU716811B2 (en) 1994-11-14 2000-03-09 Neurospheres Holdings Ltd Regulation of neural stem cell proliferation

Also Published As

Publication number Publication date
AU715255B2 (en) 2000-01-20
JP4102437B2 (ja) 2008-06-18
DE69633396D1 (de) 2004-10-21
EP0855916B1 (en) 2004-09-15
GB2306481A (en) 1997-05-07
DK0855916T3 (da) 2004-10-18
CA2235412C (en) 2010-01-19
US20040052795A1 (en) 2004-03-18
ATE275966T1 (de) 2004-10-15
AU7313896A (en) 1997-05-15
WO1997015321A1 (en) 1997-05-01
GB9521608D0 (en) 1996-01-03
ES2227610T3 (es) 2005-04-01
JPH11514373A (ja) 1999-12-07
CA2235412A1 (en) 1997-05-01
PT855916E (pt) 2004-11-30
DE69633396T2 (de) 2005-09-22
EP0855916A1 (en) 1998-08-05
US7713933B2 (en) 2010-05-11

Similar Documents

Publication Publication Date Title
AU2592600A (en) Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
GB9516287D0 (en) Pharmaceutical compositon
GB2265310B (en) Treatment of fibrotic disorders with mannose phosphates
HK1050860A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
CA2301032A1 (en) A method of preventing or treating estrogen-dependent diseases and disorders
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
AU2732001A (en) Apparatus and method of treatment of wounds, burns and immune system disorders
HK1026144A1 (en) Aryl ureas for the treatment of inflammatory or immunomodulatory diseases.
ZA968785B (en) Snatch block pins.
MY138883A (en) Use of asiatic acid for treatment of cencer
CA2229010A1 (en) Mannose-6-phosphate analogues for the treatment of wounds and fibrotic disorders with reduced scarring
AU3919001A (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
ZA966577B (en) Pharmaceutical composition.
AU2001276323A1 (en) Use of n-oleoylethanolamine for treating psoriasis
GB9723824D0 (en) Cytostatic agents
MXPA02000485A (es) 2-amino-benzoxazinonas para el tratamiento del virus de herpes simple.
UA32314A (uk) Спосіб лікування некротичного панкреатиту
UA6506A (uk) Спосіб прогнозування ефективності імунодепресивної терапії у дітей з нефротичною формою гломерулонефриту
AU1278700A (en) Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline
UA32122A (uk) Спосіб профілактики розвитку еклампсій
UA31289A (uk) Спосіб лікування запальних захворювань щелепо-лицевої ділянки
MX9702042A (es) Piridinas sustituidas por 2-arilo.
UA32146A (uk) Спосіб оцінки ефективності лікування пародонтита
UA8280A (uk) Спосіб лікування псоріазу
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь